Morris Gabriel S's Form 4 filing
Immix Biopharma, Inc. (IMMX) · filed Nov 15, 2022
- Accession no.
- 0001493152-22-032555
- Filed
- Nov 15, 2022
- Trade date
- Nov 14, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $4.89K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Morris Gabriel SCIK 0001889967 | Director, Officer (CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | Common Stock | PPurchaseAcquired | +5,200 | $0.94 | +$4,888 | 81,316 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.